Evaluation of oxidative stress in a group of adolescents exposed to a high level of aflatoxin B1 - A multi-center and multi-biomarker study

Carcinogenesis

Volumn 28, Issue 11, 2007, Pages 2347-2354

  Peng, Tao ^a,b   Li, Le Qun ^a   Peng, Min Hao ^a   Liu, Zhi Ming ^a,b   Liu, Tang Wei ^a   Guo, Ya ^a   Xiao, Kai Yin ^a   Qin, Zhong ^a   Ye, Xin Ping ^a   Mo, Xin Shao ^a   Yan, Lu Nan ^c   Lee, Bee Lam ^d   Shen, Han Ming ^d   Tamae, Kazuyoshi ^e   Wang, Lian Wen ^b   Wang, Qiao ^b   Khan, Khalid M ^b   Wang, Kai Bo ^f   Liang, Ren Xiang ^f   Wei, Zong Liang ^f   Kasai, Hiroshi ^e   Ong, Choon Nam ^d   Santella, Regina M ^b   more..

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b Department of Medicine   (United States)

^c SICHUAN UNIVERSITY   (China)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^f Fusui Cancer Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; AFLATOXIN B1; ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; DNA;

ADOLESCENT; ARTICLE; CANCER RISK; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROCHEMICAL DETECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FEMALE; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LEUKOCYTE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FUNCTION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; URINARY EXCRETION;

ADOLESCENT; AFLATOXIN B1; BIOLOGICAL MARKERS; CHILD; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; OXIDATIVE STRESS; PILOT PROJECTS; RISK ASSESSMENT;

EID: 36148939527     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm193     Document Type: Article

References (71)

1. Murray,C.J. et al. (1997) Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet, 349, 1269-1276.
2. El Serag,H.B. et al. (1999) Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med., 340, 745-750.
3. Boscb,F.X. et al. (2004) Primary liver cancer: Worldwide incidence and trends. Gastroenterology, 127, S5-S16.
4. Seeff,L.B. et al. (2006) Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Oncogene, 25, 3771-3777.
5. Wogan,G.N. (1992) Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res., 52, 2114s-2118s.
6. Wang,J.S. et al. (1999) DNA damage by mycotoxins. Mutat. Res. 424, 167-181.
7. Halliwell,B. (2007) Oxidative stress and cancer: Have we moved forward? Biochem. J., 401, 1-11.
8. Kodama,M. et al. (1990) Enzymatic and non-enzymatic formation of free radicals from aflatoxin B1. Free Radic. Res. Commun., 10 137-142.
9. Amstad,P. et al. (1984) Evidence for membrane-mediated chromosomal damage by aflatoxin B1 in human lymphocytes. Carcinogenesis, 5 719-723.
10. Liu,J. et al. (1999) Effect of Salvia miltiorrhiza on aflatoxin B1-induced oxidative stress in cultured rat hepatocytes. Free Radic. Res., 31, 559-568.
11. Shen,H.M. et al. (1994) Aflatoxin B1-induced lipid peroxidation in rat liver. Toxicol. Appl. Pharmacol., 127, 145-150.
12. Shen,H.M. et al. (1995) Aflatoxin B1-induced 8-hydroxydeoxyguanosine formation in rat hepatic DNA. Carcinogenesis 16, 419-422.
13. Kasai,H. (1997) Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat. Res., 387, 147-163.
14. Peng,T. et al. (2007) Is correction for protein concentration appropriate for protein adduct dosimetry? Hypothesis and clues from an aflatoxin B1-exposed population. Cancer Sci., 98, 140-146.
15. Yeh,F.S. et al. (1989) Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res., 49, 2506-2509.
16. Gong,Y.Y. et al. (2002) Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: Cross sectional study. BMJ, 325, 20-21.
17. Yeh,F.S. et al. (1985) Risk factors for hepatocellular carcinoma in Guangxi, People's Republic of China. Natl. Cancer Inst. Monogr. 69, 47-48.
18. Tao,P, et al. (2005) Associated factors in modulating aflatoxin B1-albumin adduct level in three Chinese populations. Dig. Dis Sci. 50, 525-532.
19. Peng,T. et al. (2003) Oxidative DNA damage in peripheral leukocytes and its association with expression and polymorphisms of hOGGI: A study of adolescents in a high risk region for hepatocellular carcinoma in China. World J. Gastroenterol., 9, 2186-2193.
20. Moriya,K. et al. (2001) Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res., 61, 4365-4370.
21. Chen,C.J. et al. (1996) Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology, 24, 38-42.
22. Kasai,H. et al. (2001) Life style and urinary 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage: Effects of exercise, working conditions, meat intake, body mass index, and smoking. Jpn. J. Cancer Res., 92, 9-15.
23. Bruner,S.D. et al. (2000) Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature, 403, 859-866.
24. Brozmanova,J. et al. (200 1) Repair of oxidative DNA damage - an important factor reducing cancer risk. Minireview. Neoplasma, 48, 85-93.
25. Wang,L.Y. et al. (1996) Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int. J. Cancer, 67, 620-625.
26. Yin,B. et al. (1995) Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody-based ELISA. Free Radic. Biol. Med., 18, 1023-1032.
27. Loft,S. et al. (1992) Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: Influence of smoking, gender and body mass index. Carcinogenesis, 13, 2241-2247.
28. Loft,S. et al. (1994) Oxidative DNA damage correlates with oxygen consumption in humans. FASEB J., 8, 534-537.
29. Gedik,C.M. et al. (2002) Oxidative stress in humans: Validation of biomarkers of DNA damage. Carcinogenesis, 23, 1441-1446.
30. Verhagen,H. et al. (1995) Reduction of oxidative DNA-damage in humans by brussels sprouts. Carcinogenesis, 16, 969-970.
31. Willard,R.C. et al. (1991) Extrapolation of toxicological and pharmacological data from animals to humans. Adv.Drug Res., 20 1-116.
32. Terry,M.B. et al. (200 1) Commentary: The impact of fetal and infant exposures along the life course. Int. J. Epidemiol., 30 95-96.
33. Wild,C.P. et al. (1990) Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment. Cancer Res., 50, 245-251.
34. Wild,C.P. et al. (1992) Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Cancer Epidemiol. Biomarkers Prev., 1, 229-234.
35. Zhu,J.Q. et al. (1987) Correlation of dietary aflatoxin B1 levels with excretion of aflatoxin M1 in human urine. Cancer Res., 47 1848-1852.
36. Groopman,J.D. et al. (1992) Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. Cancer Res., 52, 45-52.
37. Ross,R.K. et al. (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet, 339, 943-946.
38. Wild,C.P. et al. (1993) Aflatoxin, liver enzymes, and hepatitis B virus infection in Gambian children. Cancer Epidemiol. Biomarkers Prev., 2, 555-561.
39. Maki,H. et al. (1992) MutT protein specifically hydrolyses a potent mutagenic substrate for DNA synthesis. Nature, 355, 273-275.
40. Lindahl,T. (1993) Instability and decay of the primary structure of DNA. Nature, 362, 709-715.
41. Kensler,T.W. et al. (1998) Oltipraz chemoprevention trial in Qidong, People's Republic of China: Modulation of serum aflatoxin albumin adduct biomarkers. Cancer Epidemiol. Biomarkers Prev., 7, 127-134.
42. Luo,H. et al. (2006) Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: Modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine. Carcinogenesis, 27, 262-268.
43. Guengerich,F.P. et al. (1998) Activation and detoxication of aflatoxin B1. Mutat. Res., 402, 121-128.
44. Haas,C.E. et al. (2005) Cytochrome P450 mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction. Eur. J. Clin. Pharmacol., 61, 583-593.
45. Nowakowski-Gashaw,I. et al. (2002) Rapid quantification of CYP3A4 expression in human leukocytes by real-time reverse transcription-PCR. Clin. Chem., 48, 366-370.
46. Wojnowski,L. et al. (2004) Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa. Pharmacogenetics, 14, 691-700.
47. Janardan,S.K. et al. (1996) Selective expression of CYP3A5 and not CYP3A4 in human blood. Pharmacogenetics, 6, 379-385.
48. Kranendonk,M. et al. (1999) Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: Catalytic activities and mutagenicity studies. Mutat. Res., 441, 73-83.
49. Farinati,F. et al. (1999) Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection. Free Radic. Biol. Med., 27, 1284-1291.
50. Guengerich,F.P. (2000) Metabolism of chemical carcinogens. Carcinogenesis, 21, 345-351.
51. Chevion,M. et al. (2000) Human studies related to protein oxidation: Protein carbonyl content as a marker of damage. Free Radic. Res, 33 (suppl.), S99-S9108.
52. Grant,A.J. et al. (1992) Accelerated endocytosis and incomplete catabolism of radical-damaged protein. Biochim. Biophys. Acta, 1134, 203-209.
53. Panangala,V.S. et al. (1986) Effects of aflatoxin on the growth performance and immune responses of weanling swine. Am. J. Vet. Res. 47, 2062-2067.
54. Marin,D.E. et al. (2002) Changes in performance, blood parameters, humoral and cellular immune responses in weanling piglets exposed to low doses of aflatoxin. J. Anim. Sci., 80, 1250-1257.
55. Turner,P.C. et al. (2003) Modification of immune function through exposure to dietary aflatoxin in Gambian children. Environ. Health Perspect., 111, 217-220.
56. Dhenaut,A. et al. (2000) Characterization of the hOGG1 promoter and its expression during the cell cycle. Mutat. Res., 461, 109-118.
57. Asami,S. et al. (1996) Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking. Cancer Res., 56, 2546-2549.
58. Kim,H.N. et al. (200 1) Changes in DNA 8-hydroxyguanine levels, 8-hydroxyguanine repair activity, and hOGG1 and hMTH1 mRNA expression in human lung alveolar epithelial cells induced by crocidolite asbestos. Carcinogenesis, 22, 265-269.
59. Hanaoka,T. et al. (2000) A preliminary evaluation of intra- and interindividual variations of hOGG1 messenger RNA levels in peripheral blood cells as determined by a real-time polymerase chain reaction technique. Cancer Epidemiol. Biomarkers Prev., 9, 1255-1258.
60. Helbock,H.J. et al. (1998) DNA oxidation matters: The HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine. Proc. Natl Acad. Sci. USA, 95, 288-293.
61. Sattler,O. et al. (2000) Detection of oxidative base DNA damage by a new biochemical assay. Arch. Biochem. Biophys., 376, 26-33.
62. Shimoi,K. et al. (2002) Comparison between high-performance liquid chromatography and enzyme-linked immunosorbent assay for the determination of 8-hydroxy-2′-deoxyguanosine in human urine. Cancer Epidemiol. Biomarkers Prev., 11, 767-770.
63. Prieme,H. et al. (1996) Measurement of oxidative DNA injury in humans: Evaluation of a commercially available ELISA assay. In Kumpulainen,J.T. and Salonen,J.T. (eds.) Natural Antioxidants and Food Quality in Atherosclerosis and Cancer Prevention. Royal Society of Chemistry, Cambridge, UK, pp. 78-82.
64. Yoshida,R. et al. (2002) Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine values measured by an ELISA correlated well with measurements by high-performance liquid chromatography with electrochemical detection. Cancer Epidemiol. Biomarkers Prev., 11, 1076-1081.
65. Barr,D.B. et al. (2005) Urinary creatinine concentrations in the U.S. population: Implications for urinary biologic monitoring measurements. Environ, Health Perspect., 113, 192-200.
66. Wogan,G.N. et al. (1974) Carcinogenic effects of low dietary levels of aflatoxin B1 in rats. Food Cosmet. Toxicol., 12, 681-685.
67. Wilson,R. et al. (1985) Uptake and vascular transport of ingested aflatoxin. Toxicol. Lett., 29, 169-176.
68. Wang,J.S. et al. (1996) Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People,s Republic of China. Cancer Epidemiol. Biomarkers Prev., 5, 253-261.
69. Turner,P.C. et al. (2000) Hepatitis B infection and aflatoxin biomarker levels in Gambian children. Trop. Med. Int. Health, 5 837-841.
70. Sorensen,M. et al. (2003) Linking exposure to environmental pollutants with biological effect. Mutat. Res., 544, 255-271.
71. Kew,M.C. (2003) Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. N. Engl. J. Med., 23 405-409.